Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Legend Biotech Corp stock (LEGN)

Buy Legend Biotech Corp stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Legend Biotech Corp is a biotechnology business based in the US. Legend Biotech Corp shares (LEGN) are listed on the NASDAQ and all prices are listed in US Dollars. Legend Biotech Corp employs 2,000 staff and has a trailing 12-month revenue of around $342.8 million.

Our top picks for where to buy Legend Biotech Corp stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Legend Biotech Corp stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – LEGN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Legend Biotech Corp stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Legend Biotech Corp stock price (NASDAQ: LEGN)

Use our graph to track the performance of LEGN stocks over time.

Legend Biotech Corp shares at a glance

Information last updated 2024-07-08.
Latest market close$48.50
52-week range$38.60 - $77.32
50-day moving average $43.92
200-day moving average $56.73
Wall St. target price$82.31
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.58

Is it a good time to buy Legend Biotech Corp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Legend Biotech Corp price performance over time

Historical closes compared with the close of $48.5 from 2024-07-11

1 week (2024-07-05) 4.75%
1 month (2024-06-13) 11.06%
3 months (2024-04-12) -8.35%
6 months (2024-01-12) -20.19%
1 year (2023-07-13) -29.71%
2 years (2022-07-13) -11.90%
3 years (2021-07-13) 21.25%
5 years (2019-07-09) N/A

Legend Biotech Corp financials

Revenue TTM $342.8 million
Gross profit TTM $-284,006,000
Return on assets TTM -18.25%
Return on equity TTM -51.28%
Profit margin -135.92%
Book value $6.39
Market Capitalization $8.4 billion

TTM: trailing 12 months

Legend Biotech Corp share dividends

We're not expecting Legend Biotech Corp to pay a dividend over the next 12 months.

Legend Biotech Corp share price volatility

Over the last 12 months, Legend Biotech Corp's shares have ranged in value from as little as $38.6 up to $77.32. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Legend Biotech Corp's is 0.111. This would suggest that Legend Biotech Corp's shares are less volatile than average (for this exchange).

Legend Biotech Corp overview

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.

Frequently asked questions

What percentage of Legend Biotech Corp is owned by insiders or institutions?
Currently 1.317% of Legend Biotech Corp shares are held by insiders and 51.538% by institutions.
How many people work for Legend Biotech Corp?
Latest data suggests 2,000 work at Legend Biotech Corp.
When does the fiscal year end for Legend Biotech Corp?
Legend Biotech Corp's fiscal year ends in December.
Where is Legend Biotech Corp based?
Legend Biotech Corp's address is: 2101 Cottontail Lane, Somerset, NJ, United States, 08873
What is Legend Biotech Corp's ISIN number?
Legend Biotech Corp's international securities identification number is: US52490G1022

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site